Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system. - Reus, Philipp; Guthmann, Hadar; Uhlig, Nadja; Agbaria, Majd; Issmail, Leila; Eberlein, Valentina; Nordling-David, Mirjam M.; Jbara-Agbaria, Doaa; Ciesek, Sandra; Bojkova, Denisa; Cinatl, Jindrich; Burger-Kentischer, Anke; et al. (Journal of Controlled Release, 2023)